From the December 2016 issue of HealthCare Business News magazine
Georg Charles de Hevesy Nuclear Medicine Pioneer Award
Each year, SNMMI presents the Georg Charles de Hevesy Nuclear Medicine Pioneer Award to an individual for outstanding contributions to the field of nuclear medicine. De Hevesy received the 1943 Nobel Prize in chemistry for his work in determining the absorption, distribution, metabolism and elimination of radioactive compounds in the human body. His work led to the foundation of nuclear medicine as a tool for diagnosis and therapy, and he is considered to be one of the fathers of nuclear medicine. SNMMI has given the de Hevesy Award every year since 1960 to honor groundbreaking discoveries and inventions in the field of nuclear medicine.
Dr. Ross McDougall, MB, ChB, professor emeritus of radiology and medicine at Stanford University, has been named this year’s recipient of the Georg Charles de Hevesy Nuclear Medicine Pioneer Award for his contributions to nuclear medicine. McDougall has been associated with Stanford University Medical School from 1972, the first two years as a fellow and subsequently as full-time faculty. In 1989, he took over directorship of the thyroid clinic. McDougall was involved in both the Medical School and the hospital. He held numerous positions of importance at those institutions, including president of the medical center — the first faculty member elected to this post. He was director of the Nuclear Medicine Residency Program for 25 years. Since retiring as director of the thyroid clinic in 2008, he has been an active emeritus professor. McDougall conducted laboratory and clinical research and published more than 160 peer-reviewed papers and 110 book chapters, reviews and editorials. He authored or coauthored three textbooks on thyroid disease. He was appointed to the American Board of Nuclear Medicine, and he subsequently chaired the board for two years. He was vice chair of the Residency Review Committee in Nuclear Medicine. He was also a governor of the American Board of Internal Medicine for three years. He was president of the Western Regional Chapter of the Society of Nuclear Medicine and Molecular Imaging.
Back to HCB News
